Concepedia

Dange V. Kumar

DV

3

Publications

74

Citations

3

H-Index

2008

Active since

Affiliations

Theravance Biopharma (United States)(Current)

Crown Bioscience (China)

Gilead Sciences (United States)

Myriad Genetics

Dange V. Kumar is an author at Theravance Biopharma (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2008–2011

3

Publications

3

Quinolones as HCV NS5B polymerase inhibitors

Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 39 citations

, , +5

Triterpene based compounds with potent anti-maturation activity against HIV-1

David Gerrish, In Chul Kim, Dange V. Kumar et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 18 citations

, , +6

3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase

Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 17 citations

, , +6

Rows per page

1–3 of 3